Boland, Barry
Yu, Wai Haung
Corti, Olga
Mollereau, Bertrand
Henriques, Alexandre
Bezard, Erwan
Pastores, Greg M.
Rubinsztein, David C.
Nixon, Ralph A.
Duchen, Michael R.
Mallucci, Giovanna R.
Kroemer, Guido
Levine, Beth
Eskelinen, Eeva-Liisa
Mochel, Fanny
Spedding, Michael
Louis, Caroline
Martin, Olivier R.
Millan, Mark J.
Article History
First Online: 17 August 2018
Competing interests
: M.J.M. is a full-time employee of Servier Pharmaceuticals and has no other competing interests to declare. E.B. has an equity stake in Motac Holding Ltd. and receives consultancy payments from Motac Neuroscience Ltd. D.C.R. is a consultant for E3Bio and has consulted for GlaxoSmithKline, AbbVie and AstraZeneca. He has received grant support from AbbVie and AstraZeneca. B.L. is a scientific founder of Casma Therapeutics. A.H. is a full-time employee of Neuro-Sys and has no other competing interests to declare. C.L. is a full-time employee of Servier Pharmaceuticals and has no other competing interests to declare. M.S. is a consultant for Servier Pharmaceuticals and President of Spedding Research Solutions SAS, a company performing research on potential therapies for amyotrophic lateral sclerosis. The author others declare no competing interests.